These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34118504)

  • 1. Comparison of fixed dose versus train-of-four titration of cisatracurium in acute respiratory distress syndrome.
    Thompson Bastin ML; Smith RR; Bissell BD; Wolf HN; Wiegand AM; Cavagnini ME; Ahmad Y; Flannery AH
    J Crit Care; 2021 Oct; 65():86-90. PubMed ID: 34118504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Fixed Dosing vs Train of Four Titration of Cisatracurium in COVID-19 ARDS Patients.
    Banerjee O; Elefritz JL; Doepker BA; Atyia SA; Brummel NE; Smith RM; Handley D; Cape KM
    J Pharm Pract; 2024 Oct; 37(5):1082-1090. PubMed ID: 38087423
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of Cisatracurium Continuous Infusion Dose in Acute Respiratory Distress Syndrome.
    Merkel A; Massey K; Bellamy C; Miano T; Fuchs B; Candeloro C
    J Pharm Pract; 2021 Aug; 34(4):600-605. PubMed ID: 31736402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Cisatracurium Compared to Vecuronium for Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Vallabh P; Ha M; Ahern K
    J Intensive Care Med; 2023 Feb; 38(2):188-195. PubMed ID: 35821572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation.
    Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K
    J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three cisatracurium dosing strategies in acute respiratory distress syndrome: A focus on drug utilization and improvement in oxygenation.
    DiBridge JN; Rivosecchi RM; McVerry BJ; Lamberty PE; Donahoe MP; Groetzinger LM
    J Crit Care; 2021 Dec; 66():166-172. PubMed ID: 34301439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged weakness after cisatracurium infusion: a case report.
    Davis NA; Rodgers JE; Gonzalez ER; Fowler AA
    Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
    Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M
    Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atracurium Versus Cisatracurium in the Treatment of Acute Respiratory Distress Syndrome.
    Carabetta SM; Allen B; Cannon C; Hailu K; Johnson T
    J Pharm Technol; 2023 Oct; 39(5):212-217. PubMed ID: 37745727
    [No Abstract]   [Full Text] [Related]  

  • 15. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome.
    Dhonneur G; Cerf C; Lagneau F; Mantz J; Gillotin C; Duvaldestin P
    Anesth Analg; 2001 Aug; 93(2):400-4 , 3rd contents page. PubMed ID: 11473869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study.
    Hraiech S; Forel JM; Guervilly C; Rambaud R; Lehingue S; Adda M; Sylla P; Valera S; Carvelli J; Gainnier M; Papazian L; Bourenne J
    Ann Intensive Care; 2017 Dec; 7(1):79. PubMed ID: 28770545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisatracurium dosing in a patient with hyperthermia.
    Lim J; Cox J; Nguyen T; Arya R
    Am J Health Syst Pharm; 2019 Jul; 76(14):1029-1032. PubMed ID: 31361873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.
    Riley K; Yampolsky N; Hakma Z; Moussouttas M
    Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.
    Pearson AJ; Harper NJ; Pollard BJ
    Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.